Clinical Trials Logo

Tobacco Smoking clinical trials

View clinical trials related to Tobacco Smoking.

Filter by:

NCT ID: NCT05337722 Recruiting - Smoking Cessation Clinical Trials

App for Pregnancy Smoking Cessation With Peer Support

SFT
Start date: January 11, 2023
Phase: N/A
Study type: Interventional

The objectives of this project are to develop, implement, and test the feasibility and effectiveness of an artificial intelligence adaptive mobile pregnancy tobacco cessation app-based intervention using deep tailoring and a self-nominated support person, and to build mHealth research capacity in Romania. The central hypothesis is that the intervention will show evidence of feasibility and effectiveness in increasing positive support, pregnancy cessation, and postnatal abstinence. The intervention is grounded in Self-Determination Theory (SDT) and Motivational Interviewing (MI), a counselling style that is effective in assisting people to quit smoking. The app will be novel in its use of the unique functionality of smartphones, use of reinforcement learning (RL) and deep tailoring to continuously adapt the intervention, the emphasis on increasing positive support, and the use of the app by both smoker and support person. The long-term goal of the research program is to use mHealth for smoking cessation leveraging the unique functionality of smartphones and to continue building mHealth research capacity and developing research networks in Central and Eastern Europe (CEE) and other LMICs. Aim 1 (R21 phase). Develop and test the feasibility and acceptability of the SFT2.0 app-based mobile smoking cessation intervention with a support person during pregnancy and postpartum in Romania. Through a user-centered and iterative design the investigators will enhance the SFT1.0 app, deepen the tailoring, incorporate RL, expand the app for use by any support person, and test the intervention including the app and MI video counseling in a series of usability studies and a 12-week open trial (n=20). Aim 2 (R33 phase). Test the SFT2.0 app-based smoking cessation intervention in a hybrid effectiveness and implementation randomized controlled trial. The investigators will randomize 375 pregnant smokers and their support persons to i) a fixed arm, including the SFT2.0 app for both, and fixed pre- and postnatal MI counseling; ii) an RL-adaptive arm, with the app continuously optimizing as-needed MI counseling; or iii) control group. Aim 3 (R21 and R33 phases). Develop mHealth research capacity by enhancing individual and institutional research capabilities in Romania and expanding the existing international research network.

NCT ID: NCT05306158 Recruiting - Substance Use Clinical Trials

Dual Use Approach Bias Training for Nicotine Addiction

Start date: October 3, 2022
Phase: N/A
Study type: Interventional

The present project will evaluate the initial efficacy of approach bias retraining among dual combustible cigarette (CC) and electronic cigarette (ECIG) users. The study employs a randomized controlled design to follow 90 experienced dual CC/ECIG users motivated to quit nicotine as they engage in a self-guided quit attempt following approach bias retraining.

NCT ID: NCT05295953 Recruiting - Hiv Clinical Trials

Accelerated Transcranial Magnetic Stimulation (TMS) for Smoking Cessation in People Living With HIV/AIDS (PLWHA)

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

To demonstrate whether four sessions of TBS improves attentional bias and craving in PLWHA smokers compared to four sessions of sham stimulation. We hypothesize 4 sessions of TBS to the left DLPFC will significantly improve attentional bias and craving for smoking cues compared to neutral cues in a population of subjects who are smokers with HIV/AIDS compared to sham stimulation.

NCT ID: NCT05259566 Recruiting - Tobacco Smoking Clinical Trials

Potential Impact of Menthol Ban in Cigarettes and E-cigarettes

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

Menthol cigarette use remains a major public health problem and the FDA has proposed to ban menthol in cigarettes. However, additional evidence is needed to understand whether menthol flavor in e-cigarettes is important for harm reduction among menthol cigarette smokers in the context of a menthol cigarette ban. The primary aim of this project is to understand how the availability of menthol vs tobacco flavor e-cigarettes influences switching and reduces smoking behavior among adults who currently smoke menthol cigarettes to understand the potential effects in the context of a ban of menthol cigarettes.

NCT ID: NCT04720625 Recruiting - Tobacco Smoking Clinical Trials

Adapt2Quit - An Adaptive Motivational System for Socio-Economically Disadvantaged Smokers

A2Q
Start date: June 28, 2021
Phase: N/A
Study type: Interventional

The goal of this research is to test the Adapt2Quit computer program that uses participant input (message rating on how much the text motivational message might influence one to quit smoking) to select and text motivational messages that are more likely to help a user stop smoking. This Adapt2Quit system will be compared with a quitline facilitation-only control (text messages will be sent to facilitate quitline use). The primary research hypothesis is that the Adapt2Quit recommender-selected messages will be more effective than a texting quitline facilitation-only control for smoking cessation among socioeconomically disadvantaged (SED) smokers.

NCT ID: NCT04525755 Recruiting - Smoking Cessation Clinical Trials

STARS (Smoking Treatment And Remote Sampling) Study

Start date: February 8, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is a research study to find out if a smoking cessation medications, either varenicline or nicotine replacement products (patches or lozenges), are effective when given to smokers, remotely, as a one-time sample. Participants will either receive a sample of varenicline, nicotine patches and lozenges, or neither. This will be decided randomly. Participants have a 50%chance of receiving varenicline, a 25% chance of receiving nicotine products, and a 25% chance of receiving neither. If the participant is assigned to a group that receives free samples, they will be mailed to them free of charge. There is no requirement to use them, and it is completely up to the participants. There is also no requirement to quit in this study. The study lasts for six months, and will involve six total surveys. In addition, investigators ask that participants complete daily diaries (about 1 minute each) for the first 4 weeks of the study. Both varenicline and nicotine replacement products are well-established medications that help smokers quit.

NCT ID: NCT04445662 Recruiting - Tobacco Smoking Clinical Trials

Financial Incentives for Homeless Smokers: A Community-based RCT

Start date: June 10, 2021
Phase: N/A
Study type: Interventional

This community-based randomized controlled trial will test the effect of contingent financial rewards on smoking abstinence among homeless-experienced adult cigarette smokers. Participants will be recruited from 3 Boston Health Care for the Homeless Program locations: a shelter clinic, a day center clinic, and a medical center clinic. All participants will be offered a varenicline prescription and tobacco coaching. Incentive arm participants will receive escalating financial rewards for saliva cotinine levels <30 ng/ml, assessed 10 times over 12 weeks. Embedded qualitative interviews will explore the mechanisms of on-treatment and post-treatment effects of financial incentives on smoking abstinence in the context of homelessness.

NCT ID: NCT04376489 Recruiting - Tobacco Smoking Clinical Trials

Project MARS: Mobile-Assistance for Regulating Smoking

Start date: August 27, 2020
Phase: N/A
Study type: Interventional

This study aims to identify states of vulnerability for lapse, identify states of receptivity for engaging in self-regulatory activities, and investigate approaches to capitalize on states of vulnerability and receptivity to deliver real-time self-regulation prompts among smokers.

NCT ID: NCT04132232 Recruiting - Clinical trials for Tobacco Use Disorder

Smoking Reduction In Gravid Substance Use Disorders

SIGS
Start date: February 15, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to encourage smoking cessation in women with substance use disorders by providing knowledge of expired carbon monoxide. We hypothesize that women who are provided knowledge of their expired carbon monoxide and the associated percent fetal carboxyhemoglobin will have a greater success at quitting smoking during pregnancy than women who are not provided this information. A secondary aim of the study is to correlate expired carbon monoxide throughout pregnancy with infant birth weight.

NCT ID: NCT04038255 Recruiting - Tobacco Smoking Clinical Trials

Mindfulness Based Smoking Cessation Among Cancer Survivors

Start date: September 28, 2019
Phase: Phase 4
Study type: Interventional

This study will examine the effect of a mindfulness-based smoking cessation program among cancer survivors.